PATENT CLAIM ANALYSIS

Application Number: 16047418
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "400000"]

Abstract:
This invention provides compositions that include a protein and at least two protease inhibitors, method for treating diabetes mellitus, and methods for administering same, and methods for oral administration of a protein with an enzymatic activity, including orally administering same.

Claim (Index 1):
A composition comprising a protein having a molecular weight of up to 100,000 Daltons and a first protease inhibitor and a second protease inhibitor.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 95.0
- Lexical Diversity: 1.36364
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12934754', '14936758', '16000966', '13058259', '13855346']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7221690990306696
- 35 USC 102 Novelty (BERT): 0.5079228957515388
- Combined Prediction Score: 0.7007444787027566
- Mean Citation Score: 258.801288
- Max Citation Score: 273.9325
- Similarity Product: 189.9504844710231

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test